Chemomab Therapeutics announced new findings from the Phase 2 SPRING trial that highlight the potential of their treatment, nebokitug, for primary sclerosing cholangitis (PSC) and other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback